PHSSR Policy Roadmaps for Acting Early on NCDs Synthesis Report 2025

105 Acting early on NCDs The Partnership for Health System Sustainability and Resilience11 Acting early Health systems have considerable knowledge about effective NCD intervention but face implementation challenges. Technical approaches exist, including validated screening programmes, evidence-based treatment pathways, and digital coordination platforms. The benefits manifest differently across prevention levels, with primary prevention strengthening economies through improved labour productivity even as people live longer and use more healthcare, while secondary and tertiary prevention generate direct healthcare savings. Yet despite this extensive knowledge, translating evidence into practice remains profoundly uneven. This implementation gap between what we know works and what health systems actually deliver defines both the central challenge and the greatest opportunity for transformation. Health systems originally designed for acute, episodic care struggle to adapt to the continuous, coordinated management that chronic diseases require, with success varying dramatically both between and within countries. This report has identified barriers that fragment and delay care at every stage of the pathway. Fragmented governance struggles to coordinate prevention across sectors. Payment systems that reward volume over outcomes leave little time for risk assessment or prevention counselling. Geographic disparities concentrate specialists and diagnostics in urban centres, while digital systems that cannot share data miss opportunities for proactive case-finding. These challenges affect populations living with NCDs already facing disadvantage most severely, as they often have least capacity to navigate fragmented systems or access concentrated resources. The human and economic consequences of these delays are profound. Delayed diabetes diagnosis increases complication risk, with prevention opportunities often permanently lost. Cancer detected at later stages requires more intensive treatment, causes greater suffering, and has substantially worse outcomes than early-stage disease. Uncontrolled hypertension silently damages organs for years before causing strokes or heart failure that might have been entirely prevented. Beyond individual tragedies, the economic waste is significant: emergency admissions cost far more than structured management, while lost productivity from preventable disability creates substantial economic losses. These are not abstract future risks but current realities affecting millions across all eight countries studied. Why common challenges persist The persistence of these patterns across diverse health systems points to deeper structural forces. Two factors help explain why the mismatch between system design and chronic disease needs proves so resistant to change: First, the temporal dynamics of NCDs differ from institutional planning horizons. The benefits of early intervention accrue over years or decades, while costs are immediate. Budget cycles operate annually and political cycles span 4–5 years, but preventing disease progression requires sustained investment over much longer timeframes. Prevention typically receives minimal budget allocation despite evidence of cost-effectiveness, and advanced diagnostics are often restricted to late-stage disease despite their potential value in guiding early treatment. Political and financial incentives favour visible, immediate responses over investments whose benefits materialise over longer timeframes.